Jensen Investment Management

Rating #131

Eric Schoenstein

Jensen Investment Management

Portfolio value

$6.36B

Stocks

89

Performance

1 Year

+5.12%

Stock Holdings

$

%

1Y

3Y

5Y

10Y

Eric Schoenstein’s Portfolio: Q4 2025

Top10 stocks: 56.94% of the portfolio

Eric Schoenstein’s Trades: Q4 2025

Adds

New Buys

Sold Outs

Cuts

NVDA logo
NVDA

Share Count Chg. (%)

+4.33%

Price Paid
$186.14
Buy Value
$17.40M
Portfolio % Change

1.61ppt

VRSK logo
VRSK

Share Count Chg. (%)

+4.93%

Price Paid
$225.67
Buy Value
$4.73M
Portfolio % Change

0.24ppt

GWW logo
GWW

Share Count Chg. (%)

+36.52%

Price Paid
$969.91
Buy Value
$814.72K
Portfolio % Change

0.02ppt

CCK logo
CCK

Share Count Chg. (%)

+15.59%

Price Paid
$97.44
Buy Value
$747.85K
Portfolio % Change

0.03ppt

AON logo
AON

Share Count Chg. (%)

+4.98%

Price Paid
$349.16
Buy Value
$175.63K
Portfolio % Change

0.01ppt

APD logo
APD

Share Count Chg. (%)

+0.03%

Price Paid
$253.48
Buy Value
$760.44
Portfolio % Change

0.01ppt

Eric Schoenstein’s Holdings: Q4 2025

Company Name
Primary Industry
Avg. price paid
sort
Share Count Chg. (%)
sort
No of shares held
sort
Market value
sort
Portfolio % Change
sort
% of Ownership
sort
Holding period
sort
Last Transaction
Prepackaged Software
$64.10

-12.68%

1.33M
$641.69M

10.10%

0.33ppt

0.02%
51 Quarters
Q4 2025
Electronic Computers
$38.50

-14.11%

1.98M
$537.81M

8.46%

1.18ppt

0.01%
43 Quarters
Q4 2025
Computer Programming & Data
$130.56

-14.46%

1.53M
$479.58M

7.55%

2.14ppt

0.01%
38 Quarters
Q4 2025
Semiconductors
$164.40

+4.33%

2.25M
$420.32M

6.61%

1.61ppt

0.01%
3 Quarters
Q4 2025
Other Business Services
$207.94

-16.99%

482.74K
$275.59M

4.34%

0.23ppt

0.05%
42 Quarters
Q4 2025
Pharmaceutical Pres
$770.36

-46.13%

249.83K
$268.48M

4.22%

-0.17ppt

0.03%
3 Quarters
Q4 2025
Retail-Catalog & Mail-Order
$230.82

+100.00%

1.13M
$261.67M

4.12%

4.12ppt

0.01%
1 Quarter
Q4 2025
Surgical Instruments
$155.82

-40.04%

731.55K
$257.12M

4.05%

-1.55ppt

0.19%
51 Quarters
Q4 2025
Computer Programming & Data
$736.27

-8.47%

366.04K
$241.62M

3.80%

0.16ppt

0.01%
3 Quarters
Q4 2025
Pharmaceutical Pres
$129.89

-22.26%

1.87M
$234.68M

3.69%

-0.31ppt

0.11%
51 Quarters
Q4 2025
Optical Instruments
$492.21

-27.80%

189.51K
$230.27M

3.62%

0.11ppt

0.14%
11 Quarters
Q4 2025
Refuse Systems
$123.11

-7.93%

1.00M
$219.81M

3.46%

0.48ppt

0.25%
22 Quarters
Q4 2025
Insurance Agents & Brokers
$159.44

-54.94%

1.08M
$201.16M

3.17%

-2.85ppt

0.22%
19 Quarters
Q4 2025
Retail-Building Materials
$307.47

-6.83%

618.26K
$200.34M

3.15%

0.30ppt

0.25%
7 Quarters
Q4 2025
Soap & Detergents
$117.43

-11.08%

1.28M
$183.75M

2.89%

0.14ppt

0.05%
51 Quarters
Q4 2025
Prepackaged Software
$296.84

-49.16%

272.98K
$180.83M

2.85%

-1.71ppt

0.10%
34 Quarters
Q4 2025
Consumer Credit Reporting
$159.41

-19.37%

824.44K
$178.89M

2.81%

-0.44ppt

0.68%
51 Quarters
Q4 2025
Other Business Services
$118.09

-30.04%

769.45K
$171.72M

2.70%

-0.55ppt

0.66%
35 Quarters
Q4 2025
Prepackaged Software
$295.99

-14.60%

529.67K
$165.56M

2.60%

-0.10ppt

0.20%
5 Quarters
Q4 2025
Data Processing Services
$147.97

-31.44%

633.76K
$163.02M

2.56%

-0.80ppt

0.16%
51 Quarters
Q4 2025
gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.